NDC00185-0720-60: INDOMETHACIN EXTENDED-RELEASE CA.
INDOMETHACIN EXTENDED-RELEASE CA. Key specifications include special_features: WITH CHILD RESISTANT CLOSURE AND 3-PART LABEL, primary_container_type: BOTTLE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, active_medicament_medicinal_strength: 75.000 MILLIGRAMS INDOMETHACIN ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: INDOMETHACIN EXTENDED-RELEASE CAPSULES 75MG 60S BT, capsule_primary_container_content_quantity: 60.000. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-137-4629, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | WITH CHILD RESISTANT CLOSURE AND 3-PART LABEL |
| primary_container_type | BOTTLE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| active_medicament_medicinal_strength | 75.000 MILLIGRAMS INDOMETHACIN ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | INDOMETHACIN EXTENDED-RELEASE CAPSULES 75MG 60S BT |
| capsule_primary_container_content_quantity | 60.000 |
| NSN | 6505-01-137-4629 |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | WITH CHILD RESISTANT CLOSURE AND 3-PART LABEL |
| CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 60.000 |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | INDOMETHACIN EXTENDED-RELEASE CAPSULES 75MG 60S BT |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 75.000 MILLIGRAMS INDOMETHACIN ACTIVE INGREDIENT |
No substitute or cross-reference records for this part.